NS
ADMA icon

NBC Securities’s ADMA Biologics ADMA Stock Holding History

NBC Securities’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$837 Hold
100
– – ﹤0.01% 2341
2026
Q1 		$901 Hold
100
– – ﹤0.01% 2427
2025
Q4 		$1.82K Hold
100
– – ﹤0.01% 2433
2025
Q3 		$1.47K Sell
100
-5,245
-98% -$89.9K ﹤0.01% 2473
2025
Q2 		$97K Buy
+5,345
New +$109K 0.01% 1056

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

NBC Securities's ADMA Position: Q2 2026 in Review

NBC Securities held its ADMA Biologics (ADMA) position steady in Q2 2026 at 100 shares worth $837. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

NBC Securities first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $97K in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • NBC Securities held 100 shares of ADMA Biologics worth $837 as of Q2 2026.
  • NBC Securities left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2341 holding.
  • NBC Securities first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • NBC Securities's ADMA Biologics position peaked at $97K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.